Engineers Gate Manager LP

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in FDMT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$907,139

+$633,425 QoQ

Shares Held

68,206

+132.0% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#58

of 158 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,993,154 across 162 Biotechnology names. FDMT ranks #59 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$907,139	68,206	+132.0%	Shares	Sole	2026-08-14
2026-03-31	$273,714	29,400	-60.4%	Shares	Sole	2026-05-15
2025-12-31	$557,017	74,269	+209.3%	Shares	Sole	2026-02-17
2025-06-30	$89,095	24,015	-67.3%	Shares	Sole	2025-08-14
2025-03-31	$237,153	73,422	-57.2%	Shares	Sole	2025-05-15
2024-12-31	$954,820	171,422	+187.6%	Shares	Sole	2025-02-14
2024-09-30	$644,330	59,605	-5.5%	Shares	Sole	2024-11-14
2024-06-30	$1,323,398	63,049	+267.3%	Shares	Sole	2024-08-14
2024-03-31	$546,876	17,165	+110.9%	Shares	Sole	2024-05-15
2020-12-31	$337,361	8,139	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.